Patents/Assignees

Raze Therapeutics, Inc.

3 patents in portfolio

US12264132utility2025
3-phosphoglycerate Dehydrogenase Inhibitors and Uses Thereof
0 cites
US12187728utility2025
Caffeine Inhibitors of MTHFD2 and Uses Thereof
0 cites
US11634412utility2023
3-phosphoglycerate Dehydrogenase Inhibitors and Uses Thereof
0 cites